In case you missed it: Jan. 3 to Jan. 7
What you missed this week in women's health
This week's must-read stories included:
Using certain hair products during pregnancy may negatively impact maternal hormone levels
The use of hair dyes, bleach, relaxers, and mousse was associated with lower levels of sex steroid hormones in pregnant women, according to a new Rutgers study.
Detecting Candida albicans via feminine hygiene products
A home kit to detect urinary tract infections (UTIs) like Candida albicans from vaginal fluids on sanitary napkins and tampons could soon enter the clinical phase.
SMFM opts for virtual format ahead of 2022 annual meeting
The Society for Maternal-Fetal Medicine has announced its upcoming 2022 annual meeting will now be virtual.
Poll: Will new technology bring a resurgence in enthusiasm for single port surgery?
Do you expect new technology, like vNOTES, to revive the industry's enthusiasm for single-port surgery?
Expanding treatment horizons for vaginal stenosis
While it has been nearly 50 years since vaginal dilators were introduced as a therapy to decrease VS, the medical community still knows very little about the potential impact on long-term outcomes.
New blood test could predict women at risk for preeclampsia
An experimental blood test uses plasma cell-free RNA (cfRNA) to accurately predict preeclampsia as early as 16 weeks.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
